UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Alzheimer's Disease Histological and Behavioral Manifestations in Transgenic Mice Correlate with Specific Gut Microbiome State

Journal of Alzheimer's disease, 2017-01, Vol.56 (1), p.385-390

2017

Volltextzugriff (PDF)

Ceritinib in ALK-Rearranged Non–Small-Cell Lung Cancer

The New England journal of medicine, 2014-06, Vol.370 (26), p.2537-2539

2014

Volltextzugriff (PDF)

Regulative effects of curcumin spice administration on gut microbiota and its pharmacological implications

Food & nutrition research, 2017, Vol.61 (1), p.1361780-4

2017

Volltextzugriff (PDF)

Probiotics as potential therapeutic options for Alzheimer’s disease

Applied microbiology and biotechnology, 2021-10, Vol.105 (20), p.7721-7730

2021

Volltextzugriff (PDF)

Bidirectional interactions between curcumin and gut microbiota in transgenic mice with Alzheimer’s disease

Applied microbiology and biotechnology, 2020-04, Vol.104 (8), p.3507-3515

2020

Volltextzugriff (PDF)

Regulation of gut microbiota in Alzheimer’s disease mice by silibinin and silymarin and their pharmacological implications

Applied microbiology and biotechnology, 2019-09, Vol.103 (17), p.7141-7149

2019

Volltextzugriff (PDF)

Natural products and drug discovery. Can thousands of years of ancient medical knowledge lead us to new and powerful drug combinations in the fight against cancer and dementia?

EMBO reports, 2009-03, Vol.10 (3), p.194-200

2009

Volltextzugriff (PDF)

Vitamin D deficiency is associated with increased risk of Alzheimer's disease and dementia: evidence from meta-analysis

Nutrition journal, 2015-08, Vol.14 (1), p.76-76, Article 76

2015

Volltextzugriff (PDF)

Berberine: a potential multipotent natural product to combat Alzheimer's disease

Molecules, 2011-08, Vol.16 (8), p.6732-6740

2011

Volltextzugriff (PDF)

Phytosterols as bioactive food components against nonalcoholic fatty liver disease

Critical reviews in food science and nutrition, 2023, Vol.63 (20), p.4675-4686

2023

Volltextzugriff (PDF)

Microbially produced vitamin B12 contributes to the lipid-lowering effect of silymarin

Nature communications, 2023-01, Vol.14 (1), p.477-477, Article 477

2023

Volltextzugriff (PDF)

Associations Between Gut Microbiota and Alzheimer’s Disease: Current Evidences and Future Therapeutic and Diagnostic Perspectives

Journal of Alzheimer's disease, 2019-01, Vol.68 (1), p.25-31

2019

Volltextzugriff (PDF)

Impact of infection on risk of Parkinson’s disease: a quantitative assessment of case-control and cohort studies

Journal of neurovirology, 2019-04, Vol.25 (2), p.221-228

2019

Volltextzugriff (PDF)

Associations Between Obesity and Alzheimer’s Disease: Multiple Bioinformatic Analyses

Journal of Alzheimer's disease, 2021-01, Vol.80 (1), p.271-281

2021

Volltextzugriff (PDF)

Assessment of vitamin D levels in type 1 and type 2 diabetes patients: Results from metaanalysis

Molecular nutrition & food research, 2016-05, Vol.60 (5), p.1059-1067

2016

Volltextzugriff (PDF)

Regulatory effects of transition metals supplementation/deficiency on the gut microbiota

Applied microbiology and biotechnology, 2021-02, Vol.105 (3), p.1007-1015

2021

Volltextzugriff (PDF)

Alzheimer’s Disease and Risk of Hip Fracture : A Meta-Analysis Study

TheScientificWorld, 2012-01, Vol.2012 (2012), p.1-5

2012

Volltextzugriff (PDF)

Effect of vitamin E supplementation on aminotransferase levels in patients with NAFLD, NASH, and CHC: Results from a meta-analysis

Nutrition (Burbank, Los Angeles County, Calif.), 2014-09, Vol.30 (9), p.986-991

2014

Volltextzugriff (PDF)

Molecular Basis of Inhibitory Activities of Berberine against Pathogenic Enzymes in Alzheimer's Disease

TheScientificWorld, 2012-01, Vol.2012 (2012), p.1-4

2012

Volltextzugriff (PDF)

Neuroprotective Effects and Mechanisms of Curcumin-Cu(II) and -Zn(II) Complexes Systems and Their Pharmacological Implications

Nutrients, 2017-12, Vol.10 (1), p.28

2017

Volltextzugriff (PDF)

Comparative analysis of heparin affecting the biochemical properties of chicken and murine prion proteins

PloS one, 2021-02, Vol.16 (2), p.e0247248-e0247248

2021

Volltextzugriff (PDF)

Causal association evaluation of diabetes with Alzheimer's disease and genetic analysis of antidiabetic drugs against Alzheimer's disease

Cell & bioscience, 2022-03, Vol.12 (1), p.28-28, Article 28

2022

Volltextzugriff (PDF)

Low uric acid levels in patients with Parkinson's disease: evidence from meta-analysis

BMJ open, 2013-01, Vol.3 (11), p.e003620-e003620

2013

Volltextzugriff (PDF)

Vitamin E therapy on aminotransferase levels in NAFLD/NASH patients

Nutrition (Burbank, Los Angeles County, Calif.), 2015-06, Vol.31 (6), p.899-899

Ji, Hong-Fang, Ph.D

2015

Volltextzugriff (PDF)

The pharmacology of curcumin: is it the degradation products?

Trends in molecular medicine, 2012-03, Vol.18 (3), p.138-144

2012

Volltextzugriff (PDF)

1 – 25 von 389

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(305)
Mit Volltextzugriff
(345)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Alzheimer's Disease Histological and Behavioral Manifestations in Transgenic Mice Correlate with Specific Gut Microbiome State

Ceritinib in ALK-Rearranged Non–Small-Cell Lung Cancer

Regulative effects of curcumin spice administration on gut microbiota and its pharmacological implications

Probiotics as potential therapeutic options for Alzheimer’s disease

Bidirectional interactions between curcumin and gut microbiota in transgenic mice with Alzheimer’s disease

Regulation of gut microbiota in Alzheimer’s disease mice by silibinin and silymarin and their pharmacological implications

Natural products and drug discovery. Can thousands of years of ancient medical knowledge lead us to new and powerful drug combinations in the fight against cancer and dementia?

Vitamin D deficiency is associated with increased risk of Alzheimer's disease and dementia: evidence from meta-analysis

Berberine: a potential multipotent natural product to combat Alzheimer's disease

Phytosterols as bioactive food components against nonalcoholic fatty liver disease

Microbially produced vitamin B12 contributes to the lipid-lowering effect of silymarin

Associations Between Gut Microbiota and Alzheimer’s Disease: Current Evidences and Future Therapeutic and Diagnostic Perspectives

Impact of infection on risk of Parkinson’s disease: a quantitative assessment of case-control and cohort studies

Associations Between Obesity and Alzheimer’s Disease: Multiple Bioinformatic Analyses

Assessment of vitamin D levels in type 1 and type 2 diabetes patients: Results from metaanalysis

Regulatory effects of transition metals supplementation/deficiency on the gut microbiota

Alzheimer’s Disease and Risk of Hip Fracture : A Meta-Analysis Study

Effect of vitamin E supplementation on aminotransferase levels in patients with NAFLD, NASH, and CHC: Results from a meta-analysis

Molecular Basis of Inhibitory Activities of Berberine against Pathogenic Enzymes in Alzheimer's Disease

Neuroprotective Effects and Mechanisms of Curcumin-Cu(II) and -Zn(II) Complexes Systems and Their Pharmacological Implications

Comparative analysis of heparin affecting the biochemical properties of chicken and murine prion proteins

Causal association evaluation of diabetes with Alzheimer's disease and genetic analysis of antidiabetic drugs against Alzheimer's disease

Low uric acid levels in patients with Parkinson's disease: evidence from meta-analysis

Vitamin E therapy on aminotransferase levels in NAFLD/NASH patients

The pharmacology of curcumin: is it the degradation products?

Suchergebnisse filtern